Market Tracker

12/09 5:16pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

13.40
Delayed Data
As of Dec 09
 +0.15 / +1.13%
Today’s Change
12.28
Today|||52-Week Range
44.86
-68.66%
Year-to-Date

Today’s Trading

Previous close13.25
Today’s open13.25
Day’s range13.15 - 13.80
Volume1,459,974
Average volume (3 months)1,248,332
Market cap$990.0M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)-18.21%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+44.36%
P/E ratioNM
Price/Sales3.58
Price/Book0.92

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...+0.20+0.94%
MGNXMacroGenics Inc-0.07-0.26%
SGYPSynergy Pharmaceutic...-0.32-5.78%
PTLAPortola Pharmaceutic...+0.40+2.20%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)$0.18
Annual revenue (last year)$860.5M
Annual profit (last year)$39.0M
Net profit margin4.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts